Clinical Trial Update: Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating Bucelipase alfa (BSSL) in cystic fibrosis patients with exocrine pancreatic insufficiency. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency

Drugs mentioned

• Bucelipase alfa (bucelipase alfa)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Cystic Fibrosis, Exocrine Pancreatic Insufficiency | Phase 2 | Status: COMPLETED | Results posted: 2014-11-18